Interim Recommendation of the Advisory Committee on…
Summary of Evidence for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 Years
The body of evidence regarding efficacy of the Novavax COVID-19 vaccine among persons aged ≥18 years consisted of data from one randomized,…